|
1
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2021. CA Cancer J Clin. 71:7–33. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cao M and Chen W: Epidemiology of lung
cancer in China. Thorac Cancer. 10:3–7. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
McIntyre A and Ganti AK: Lung cancer-A
global perspective. J Surg Oncol. 115:550–554. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liloglou T, Bediaga NG, Brown BR, Field JK
and Davies MP: Epigenetic biomarkers in lung cancer. Cancer Lett.
342:200–212. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wood SL, Pernemalm M, Crosbie PA and
Whetton AD: The role of the tumor-microenvironment in lung
cancer-metastasis and its relationship to potential therapeutic
targets. Cancer Treat Rev. 40:558–566. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Visconti R, Morra F, Guggino G and Celetti
A: The between now and then of lung cancer chemotherapy and
immunotherapy. Int J Mol Sci. 18:E13742017. View Article : Google Scholar
|
|
7
|
Shi YX, Yin JY, Shen Y, Zhang W, Zhou HH
and Liu ZQ: Genome-scale analysis identifies NEK2, DLGAP5 and ECT2
as promising diagnostic and prognostic biomarkers in human lung
cancer. Sci Rep. 7:80722017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Michalak EM, Burr ML, Bannister AJ and
Dawson MA: The roles of DNA, RNA and histone methylation in ageing
and cancer. Nat Rev Mol Cell Biol. 20:573–589. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jones PA and Baylin SB: The fundamental
role of epigenetic events in cancer. Nat Rev Genet. 3:415–428.
2002. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dawson MA and Kouzarides T: Cancer
epigenetics: From mechanism to therapy. Cell. 150:12–27. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Seijo LM, Peled N, Ajona D, Boeri M, Field
JK, Sozzi G, Pio R, Zulueta JJ, Spira A, Massion PP, et al:
Biomarkers in lung cancer screening: achievements, promises, and
challenges. J Thorac Oncol. 14:343–357. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Choo KB: Epigenetics in disease and
cancer. Malays J Pathol. 33:61–70. 2011.PubMed/NCBI
|
|
13
|
Schübeler D: Function and information
content of DNA methylation. Nature. 517:321–326. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shinjo K and Kondo Y: Targeting cancer
epigenetics: Linking basic biology to clinical medicine. Adv Drug
Deliv Rev. 95:56–64. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jones PA, Issa JPJ and Baylin S: Targeting
the cancer epigenome for therapy. Nat Rev Genet. 17:630–641. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schiffmann I, Greve G, Jung M and Lübbert
M: Epigenetic therapy approaches in non-small cell lung cancer:
Update and perspectives. Epigenetics. 11:858–870. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hatakeyama S: TRIM family proteins: Roles
in autophagy, immunity, and carcinogenesis. Trends Biochem Sci.
42:297–311. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hatakeyama S: TRIM proteins and cancer.
Nat Rev Cancer. 11:792–804. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Napolitano LM and Meroni G: TRIM family:
Pleiotropy and diversification through homomultimer and
heteromultimer formation. IUBMB Life. 64:64–71. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang S, Zhang Y, Huang J, Wong CC, Zhai J,
Li C, Wei G, Zhao L, Wang G, Wei H, et al: TRIM67 activates p53 to
suppress colorectal cancer initiation and progression. Cancer Res.
79:4086–4098. 2019.PubMed/NCBI
|
|
21
|
Cambiaghi V, Giuliani V, Lombardi S,
Marinelli C, Toffalorio F and Pelicci PG: TRIM proteins in cancer.
Adv Exp Med Biol. 770:77–91. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Meroni G and Diez-Roux G: TRIM/RBCC, a
novel class of ‘single protein RING finger’ E3 ubiquitin ligases.
BioEssays. 27:1147–1157. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Reymond A, Meroni G, Fantozzi A, Merla G,
Cairo S, Luzi L, Riganelli D, Zanaria E, Messali S, Cainarca S, et
al: The tripartite motif family identifies cell compartments. EMBO
J. 20:2140–2151. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Short KM and Cox TC: Subclassification of
the RBCC/TRIM superfamily reveals a novel motif necessary for
microtubule binding. J Biol Chem. 281:8970–8980. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Herbst RS, Morgensztern D and Boshoff C:
The biology and management of non-small cell lung cancer. Nature.
553:446–454. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shi YX, Wang Y, Li X, Zhang W, Zhou HH,
Yin JY and Liu ZQ: Genome-wide DNA methylation profiling reveals
novel epigenetic signatures in squamous cell lung cancer. BMC
Genomics. 18:9012017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Robles AI, Arai E, Mathé EA, Okayama H,
Schetter AJ, Brown D, Petersen D, Bowman ED, Noro R, Welsh JA, et
al: An integrated prognostic classifier for stage I lung
adenocarcinoma based on mRNA, microRNA, and DNA methylation
biomarkers. J Thorac Oncol. 10:1037–1048. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mansfield AS, Wang L, Cunningham JM, Jen
J, Kolbert CP, Sun Z and Yang P: DNA methylation and RNA expression
profiles in lung adenocarcinomas of never-smokers. Cancer Genet.
208:253–260. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Selamat SA, Chung BS, Girard L, Zhang W,
Zhang Y, Campan M, Siegmund KD, Koss MN, Hagen JA, Lam WL, et al:
Genome-scale analysis of DNA methylation in lung adenocarcinoma and
integration with mRNA expression. Genome Res. 22:1197–1211. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gentleman RC, Carey VJ, Bates DM, Bolstad
B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al:
Bioconductor: Open software development for computational biology
and bioinformatics. Genome Biol. 5:R802004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Smyth GK: limma: Linear models for
microarray data. Bioinformatics and Computational Biology Solutions
Using R and Bioconductor. pp. 397–420. Springer; New York, NY:
2005, View Article : Google Scholar
|
|
32
|
Ghosh D: Incorporating the empirical null
hypothesis into the Benjamini-Hochberg procedure. Stat Appl Genet
Mol Biol. 11:/j/sagmb.2012.11.issue-4/1544-6115.1735/1544-6115.1735.xml2012.doi:
10.1515/1544-6115.1735. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Goldman M, Craft B, Swatloski T, Cline M,
Morozova O, Diekhans M, Haussler D and Zhu J: The UCSC Cancer
Genomics Browser: Update 2015. Nucleic Acids Res. 43:D812–D817.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huang WY, Hsu SD, Huang HY, Sun YM, Chou
CH, Weng SL and Huang HD: MethHC: A database of DNA methylation and
gene expression in human cancer. Nucleic Acids Res. 43:D856–D861.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Watanabe M and Hatakeyama S: TRIM proteins
and diseases. J Biochem. 161:135–144. 2017.PubMed/NCBI
|
|
37
|
Zhan W and Zhang S: TRIM proteins in lung
cancer: Mechanisms, biomarkers and therapeutic targets. Life Sci.
268:1189852021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tomida S, Koshikawa K, Yatabe Y, Harano T,
Ogura N, Mitsudomi T, Some M, Yanagisawa K, Takahashi T, Osada H,
et al: Gene expression-based, individualized outcome prediction for
surgically treated lung cancer patients. Oncogene. 23:5360–5370.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Baylin SB and Jones PA: A decade of
exploring the cancer epigenome - biological and translational
implications. Nat Rev Cancer. 11:726–734. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Esteller M: Epigenetics in cancer. N Engl
J Med. 358:1148–1159. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mari-Alexandre J, Diaz-Lagares A, Villalba
M, Juan O, Crujeiras AB, Calvo A and Sandoval J: Translating cancer
epigenomics into the clinic: Focus on lung cancer. Transl Res.
189:76–92. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Clark SJ and Melki J: DNA methylation and
gene silencing in cancer: Which is the guilty party? Oncogene.
21:5380–5387. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
You JS and Jones PA: Cancer genetics and
epigenetics: Two sides of the same coin? Cancer Cell. 22:9–20.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Diaz-Lagares A, Mendez-Gonzalez J, Hervas
D, Saigi M, Pajares MJ, Garcia D, Crujerias AB, Pio R, Montuenga
LM, Zulueta J, et al: A novel epigenetic signature for early
diagnosis in lung cancer. Clin Cancer Res. 22:3361–3371. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Liu TY, Chen J, Shang CL, Shen HW, Huang
JM, Liang YC, Wang W, Zhao YH, Liu D, Shu M, et al: Tripartite
motif containing 62 is a novel prognostic marker and suppresses
tumor metastasis via c-Jun/Slug signaling-mediated
epithelial-mesenchymal transition in cervical cancer. J Exp Clin
Cancer Res. 35:1702016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chen N, Balasenthil S, Reuther J and
Killary AM: DEAR1, a novel tumor suppressor that regulates cell
polarity and epithelial plasticity. Cancer Res. 74:5683–5689. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Tamaddoni A, Mohammadi E, Sedaghat F,
Qujeq D and As'Habi A: The anticancer effects of curcumin via
targeting the mammalian target of rapamycin complex 1 (mTORC1)
signaling pathway. Pharmacol Res. 156:1047982020. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lane HA and Breuleux M: Optimal targeting
of the mTORC1 kinase in human cancer. Curr Opin Cell Biol.
21:219–229. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Tansey WP: Mammalian MYC proteins and
cancer. New J Sci. 2014.1–27. 2014.https://doi.org/10.1155/2014/757534 View Article : Google Scholar
|
